May 18 (Reuters) - Elekta AB (publ) EKTAb.ST :
* GENESISCARE MAKES MAJOR INVESTMENT IN ELEKTA CANCER TREATMENT EQUIPMENT AS IT ENTERS U.S. MARKET
* ORDER VALUE BOOKED DURING Q1 OF ELEKTA'S FISCAL YEAR 2020/21 WILL BE AROUND USD 100 MILLION (APPROX. SEK 1 BILLION).
* CLOSES MAJOR ORDER OF AROUND USD 200 MILLION, INCLUDING NUMEROUS LINACS, SERVICE AGREEMENTS AND 11 ELEKTA UNITY SYSTEMS, SURPASSING TARGET OF 75
* TOTAL ORDER VALUE IS AROUND USD 200 MILLION (APPROX. SEK 2 BILLION) OVER NEXT FIVE YEARS
* FIRST DELIVERIES OF ORDER ARE PLANNED FOR JULY 2020.